These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38238084)

  • 1. Circulating leptin in patients with nonalcoholic fatty liver disease-related liver fibrosis: a systematic review and a meta-analysis.
    Makri ES; Evripidou K; Polyzos SA
    J Gastroenterol Hepatol; 2024 May; 39(5):806-817. PubMed ID: 38238084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Polyzos SA; Aronis KN; Kountouras J; Raptis DD; Vasiloglou MF; Mantzoros CS
    Diabetologia; 2016 Jan; 59(1):30-43. PubMed ID: 26407715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating adiponectin in patients with nonalcoholic fatty liver disease-related liver fibrosis: A systematic review and a meta-analysis.
    Tontikidou C; Makri ES; Evripidou K; Goulis DG; Goulas A; Polyzos SA
    J Gastroenterol Hepatol; 2022 Oct; 37(10):1853-1864. PubMed ID: 35748302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor necrosis factor-α levels in non-alcoholic fatty liver disease: A systematic review and a meta-analysis.
    Potoupni V; Georgiadou M; Chatzigriva E; Polychronidou G; Markou E; Zapantis Gakis C; Filimidou I; Karagianni M; Anastasilakis D; Evripidou K; Ftergioti A; Togkaridou M; Tsaftaridis N; Apostolopoulos A; Polyzos SA
    J Gastroenterol Hepatol; 2021 Nov; 36(11):3002-3014. PubMed ID: 34289181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating chemerin levels in metabolic-associated fatty liver disease: a systematic review and meta-analysis.
    Ren Q; Wang H; Zeng Y; Fang X; Wang M; Li D; Huang W; Xu Y
    Lipids Health Dis; 2022 Mar; 21(1):27. PubMed ID: 35236351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irisin in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
    Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical, anthropometric and dietary factors associated with the development of fibrosis in patients with nonalcoholic fatty liver disease.
    Gómez de la Cuesta S; Aller de la Fuente R; Tafur Sánchez C; Izaola O; García Sánchez C; Mora N; González Hernández JM; de Luis Román D
    Rev Esp Enferm Dig; 2018 May; 110(5):292-298. PubMed ID: 29338271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease.
    Sayın O; Tokgöz Y; Arslan N
    J Pediatr Endocrinol Metab; 2014 May; 27(5-6):479-84. PubMed ID: 24468600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Makri E; Orfanidou M; Makri ES; Goulas A; Terpos E; Polyzos SA
    J Clin Exp Hepatol; 2024; 14(3):101353. PubMed ID: 38435724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating lipoprotein(a) in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Nikoli A; Orfanidou M; Goulas A; Goulis DG; Polyzos SA
    J Gastroenterol Hepatol; 2024 Dec; 39(12):2572-2581. PubMed ID: 39417560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD.
    Caussy C; Hsu C; Singh S; Bassirian S; Kolar J; Faulkner C; Sinha N; Bettencourt R; Gara N; Valasek MA; Schnabl B; Richards L; Brenner DA; Hofmann AF; Loomba R
    Aliment Pharmacol Ther; 2019 Jan; 49(2):183-193. PubMed ID: 30506692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of a Simulation Model to Estimate Long-term Outcomes in Patients with Nonalcoholic Fatty Liver Disease.
    Chhatwal J; Dalgic OO; Chen W; Samur S; Bethea ED; Xiao J; Hur C; Corey KE; Loomba R
    JAMA Netw Open; 2022 Sep; 5(9):e2230426. PubMed ID: 36098969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease.
    Charlton M; Angulo P; Chalasani N; Merriman R; Viker K; Charatcharoenwitthaya P; Sanderson S; Gawrieh S; Krishnan A; Lindor K
    Hepatology; 2008 Feb; 47(2):484-92. PubMed ID: 18220286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Zhou Z; Chen H; Ju H; Sun M
    Lipids Health Dis; 2017 Sep; 16(1):180. PubMed ID: 28931435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
    Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association between Circulating Adipocytokine Omentin Levels and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Khodashahi R; Aliakbarian M; Ferns GA; Arjmand MH
    Curr Mol Med; 2024; 24(11):1374-1381. PubMed ID: 37711002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Review and Meta-analysis of Circulating Fetuin-A Levels in Nonalcoholic Fatty Liver Disease.
    Liu S; Xiao J; Zhao Z; Wang M; Wang Y; Xin Y
    J Clin Transl Hepatol; 2021 Feb; 9(1):3-14. PubMed ID: 33604250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CORRELATION BETWEEN NONALCOHOLIC FATTY LIVER DISEASE FEATURES AND LEVELS OF ADIPOKINES AND INFLAMMATORY CYTOKINES AMONG MORBIDLY OBESE INDIVIDUALS.
    Baltieri L; Chaim EA; Chaim FDM; Utrini MP; Gestic MA; Cazzo E
    Arq Gastroenterol; 2018; 55(3):247-251. PubMed ID: 30540086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin-to-adiponectin ratio in obese adolescents with nonalcoholic fatty liver disease.
    Angın Y; Arslan N; Kuralay F
    Turk J Pediatr; 2014; 56(3):259-66. PubMed ID: 25341597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipokines and C-reactive protein in relation to bone mineralization in pediatric nonalcoholic fatty liver disease.
    Pacifico L; Bezzi M; Lombardo CV; Romaggioli S; Ferraro F; Bascetta S; Chiesa C
    World J Gastroenterol; 2013 Jul; 19(25):4007-14. PubMed ID: 23840146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.